PlatformQ Health was pleased to attend the National Organization for Rare DisordersⓇ (NORD) 2019 Rare Diseases & Orphan Products Breakthrough Summit. This year’s record-breaking NORD Summit included over 900 registrants in two days of powerful panels, breakout sessions and networking in our nation’s capital. Every year, the Summit is a place...
The end of the summer brings many things - schools are back in session, the air is crisp…and flu season is right around the corner. While most people who get sick with influenza will have mild symptoms, some people will get very sick. Older adults, young children, pregnant women, and...
PlatformQ Health is pleased to be able to share outcomes from a recent patient/caregiver program on clinical trials at the ASCO Quality Care Symposium in San Diego, CA this September. The poster session, titled Patient beliefs and behaviors concerning clinical trials for blood cancers: Outcomes from live online education...
Following two successful programs, produced in partnership with the Carcinoid Cancer Foundation, PlatformQ Health is pleased to announce an all-new program for patients and caregivers on Neuroendocrine Tumors that will premiere live at 1pm ET on August 14, 2019 on CancerCoachLive. The two previous programs focused specifically on carcinoid syndrome,...
Basal insulin is also referred to as background insulin. It is that insulin which the pancreas produces and is present all the time. In contrast, bolus insulin is the extra amount of insulin the pancreas produces in response to glucose intake. In patients with T1DM, the pancreas stops making insulin...
PlatformQ Health is pleased to announce a three-part educational series for the clinicians treating and families facing multiple sclerosis (MS), created in collaboration with the National Multiple Sclerosis Society (NMSS) and the Consortium of Multiple Sclerosis Centers (CMSC). On June 20, 2019, two special programs will be streamed live –...
PlatformQ Health is pleased to announce our education team will present a poster session at the 79th annual scientific session of the American Diabetes Association (ADA). The poster will detail a recent PlatformQ Health aligned educational activity for HCPs and patients in diabetes, that was released in collaboration with the...
[vc_row][vc_column width="2/3"][vc_column_text]PlatformQ Health will be in Chicago for the 2019 ASCO Annual Meeting May 31 – June 4 and is pleased to have an abstract accepted for online publication for the 2019 meeting. This year’s abstract puts the patient front and center, demonstrating the impact of two video-based patient activities...
PlatformQ Health is pleased to announce our education team will present three poster sessions at this year’s Annual Meeting of the American Academy of Neurology (AAN), which will share insights from recent educational series in neurological diseases, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Lennox-Gastaut Syndrome, and Multiple Sclerosis (MS). “We have...
Curious about our work with partners? Check out this downloadable overview! Want more information? Email us now. Spring is finally upon us! As we clear out the old and bring in the new, our team was inspired to look back at all that we've been able to accomplish with our...
[vc_row][vc_column][vc_column_text] Our team works with amazing partners like GBS|CIDP Foundation International, the Carcinoid Cancer Foundation, and the ILD Collaborative to create education for the rare disease community all year round: the healthcare professionals who treat these conditions, and the patients and caregivers who live with them. On Rare Disease Day...
Join our experts for a one-hour CME presentation as they appraise clinical safety and efficacy data for new and emerging therapeutic agents for the treatment of hATTR amyloidosis. hATTR amyloidosis is a genetic disorder that is characterized by the deposition of amyloid (abnormal proteins) in multiple organs. It often...